IP Verse

Teva Pharmaceuticals USA, Inc vs Bayer Pharma AG et al.

The detailed information for PTAB case with proceeding number IPR2022-01513 filed by Teva Pharmaceuticals USA, Inc against Bayer Pharma AG et al. on Sep 9, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2022-01513
Filing Date: Sep 9, 2022
Petitioner: Teva Pharmaceuticals USA, Inc
Respondent: Bayer Pharma AG et al.
Status: Final Written Decision - Appealed
Respondent Application Number: 16264032
Respondent Tech Center: 1600
Respondent Patent Number: 10828310
Institution Decision Date: Oct 19, 2022
Termination Date: Jul 28, 2023

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Determining All Challenged Claims Unpatentable 35 U.S.C. § 318(a)	Jul 28, 2023	PAPER	BOARD
Institution Decision: Joined	Oct 19, 2022	PAPER	BOARD
Joint Notice of Stipulation Concerning Joinder	Oct 6, 2022	PAPER	PATENT OWNER
EX1021 - Teleconference Transcript	Oct 5, 2022	EXHIBIT	PETITIONER
Petitioner's Updated Exhibit List	Oct 5, 2022	PAPER	PETITIONER
EXPUNGED	Sep 30, 2022	PAPER	BOARD
NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE	Sep 30, 2022	PAPER	BOARD
Patent Owner Power of Attorney	Sep 21, 2022	PAPER	PATENT OWNER
Patent Owner Mandatory Notices	Sep 21, 2022	PAPER	PATENT OWNER
EX1001 - US10828310	Sep 9, 2022	EXHIBIT	PETITIONER
EX1003 - Zusman CV	Sep 9, 2022	EXHIBIT	PETITIONER
EX1004 - File History of U.S. Pat. App. No. 16264032 (Part 1 of 3)	Sep 9, 2022	EXHIBIT	PETITIONER
EX1004 - File History of U.S. Pat. App. No. 16264032 (Part 2 of 3)	Sep 9, 2022	EXHIBIT	PETITIONER
EX1004 - File History of U.S. Pat. App. No. 16264032 (Part 3 of 3)	Sep 9, 2022	EXHIBIT	PETITIONER
EX1005 - EMA Xarelto Assessment Report	Sep 9, 2022	EXHIBIT	PETITIONER
EX1006 - Foley 2016	Sep 9, 2022	EXHIBIT	PETITIONER
EX1007 - Plosker 2014	Sep 9, 2022	EXHIBIT	PETITIONER
EX1008 - Amsterdam	Sep 9, 2022	EXHIBIT	PETITIONER
EX1009 - Kubitza 2006	Sep 9, 2022	EXHIBIT	PETITIONER
EX1011 - Barstow 2017	Sep 9, 2022	EXHIBIT	PETITIONER
EX1012 - Braunwald Excerpt	Sep 9, 2022	EXHIBIT	PETITIONER
EX1013 - Dressman 2012	Sep 9, 2022	EXHIBIT	PETITIONER
EX1014 - Mega 2009	Sep 9, 2022	EXHIBIT	PETITIONER
EX1015 - Mega 2012	Sep 9, 2022	EXHIBIT	PETITIONER
EX1016 - FDA Approval Announcement	Sep 9, 2022	EXHIBIT	PETITIONER
EX1017 - Deichmann 2016	Sep 9, 2022	EXHIBIT	PETITIONER
EX1018 - Siegal	Sep 9, 2022	EXHIBIT	PETITIONER
EX1019 - EMA Xarelto Webpage	Sep 9, 2022	EXHIBIT	PETITIONER
EX1020 - Sivolella 4884-8037-0954 v.1	Sep 9, 2022	EXHIBIT	PETITIONER
Petitioner's Power of Attorney	Sep 9, 2022	PAPER	PETITIONER
EX1002 - IPR2022-00517 Zusman Declaration	Sep 9, 2022	EXHIBIT	PETITIONER
EX1010 - US20040242660 (Straub)	Sep 9, 2022	EXHIBIT	PETITIONER
Petition for Inter Partes Review	Sep 9, 2022	PAPER	PETITIONER
Petitioner's Motion for Joinder	Sep 9, 2022	PAPER	PETITIONER